Estrogen-receptor biology: continuing progress and therapeutic implications.
about
From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen responseChaperoning steroid hormone signaling via reversible acetylation.Clinical utility of letrozole in the treatment of breast cancer: a Chinese perspectiveSteroid hormones, steroid receptors, and breast cancer stem cellsThe therapeutic target of estrogen receptor-alpha36 in estrogen-dependent tumorsManagement of patients with hormone receptor-positive breast cancer with visceral disease: challenges and treatment optionsComputational methods in drug discoveryEstrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the Tamoxifen and Exemestane Adjuvant Multinational trial.Resistance to therapy in estrogen receptor positive and human epidermal growth factor 2 positive breast cancers: progress with latest therapeutic strategiesAre Estrogen Receptor Genomic Aberrations Predictive of Hormone Therapy Response in Breast Cancer?Enhancing Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer: Cotargeting Signaling Pathways17β-Estradiol inhibits phosphorylation of stromal interaction molecule 1 (STIM1) protein: implication for store-operated calcium entry and chronic lung diseases.Aldosterone's rapid, nongenomic effects are mediated by striatin: a modulator of aldosterone's effect on estrogen action.Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma.No germline mutations in supposed tumour suppressor genes SAFB1 and SAFB2 in familial breast cancer with linkage to 19p.Comparative study on ChIP-seq data: normalization and binding pattern characterizationTumor suppressor p53 and estrogen receptors in nuclear-mitochondrial communication.Adenosine A1 receptor, a target and regulator of estrogen receptoralpha action, mediates the proliferative effects of estradiol in breast cancer.Correlation between estrogen receptor β expression and the curative effect of endocrine therapy in breast cancer patients.Inference of hierarchical regulatory network of estrogen-dependent breast cancer through ChIP-based data.Disruption of estrogen receptor alpha-p53 interaction in breast tumors: a novel mechanism underlying the anti-tumor effect of radiation therapyThe cholesterol metabolite 25-hydroxycholesterol activates estrogen receptor α-mediated signaling in cancer cells and in cardiomyocytesInteraction of the double-strand break repair kinase DNA-PK and estrogen receptor-alphaThe mechanistic target for rapamycin pathway is related to the phosphorylation score for estrogen receptor-α in human breast tumors in vivo.Small leucine zipper protein functions as a negative regulator of estrogen receptor α in breast cancer.Mediator and human disease17β-estradiol regulates giant vesicle formation via estrogen receptor-alpha in human breast cancer cells.The ERalpha coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epitheliumNon-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice.Leptin mediates tumor-stromal interactions that promote the invasive growth of breast cancer cellsProteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer.Lapatinib in the Treatment of Hormone Receptor-Positive/ErbB2-Positive Breast CancerHow many etiological subtypes of breast cancer: two, three, four, or more?Deconstructing the molecular portraits of breast cancer.ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancerOncogenic HER2{Delta}16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors.Downregulation of miR-342 is associated with tamoxifen resistant breast tumors.Anchoring ethinylestradiol induced gene expression changes with testicular morphology and reproductive function in the medakaPeritoneal mesothelioma in a woman who has survived for seven years: a case report.Overcoming endocrine resistance in metastatic breast cancer: Current evidence and future directions.
P2860
Q24313831-8B0B594B-48DE-482A-9244-30828EDED54CQ25257831-A001AB4D-C7F8-4B49-9B7E-DF9766E45562Q26752834-70045157-197C-4294-A0D3-CDCD54FA1564Q26799113-65A9A164-EEA2-4AAE-88D6-468CB4260220Q26829978-01A7EDAC-B4AD-4FF6-A148-EA0B90688FEFQ26995549-A607DE3C-87E1-4791-AEA2-CBBDC438B472Q26997089-CE29F1A9-94D3-486F-B479-560DD4490172Q27851630-F3CE66F1-1716-4658-B8F7-B069DE26CA13Q28072897-17906EE7-069C-46B2-8F69-D3D58B66DDF2Q28074060-75A40391-EFF9-48E3-B30F-E22024F702D7Q28084585-A0209118-3485-4842-942E-F8838E6A679FQ30409431-D1D47EBA-C720-4F85-827E-416700DD0E22Q30410186-870F0175-D6A7-4C1C-914F-CA9518B5D7C7Q33347137-E40EABBA-56E2-4D16-AB91-82451267BF64Q33392484-430552BD-1538-47D6-81E8-5EE7C6A4D321Q33475519-D775BBCF-D2AF-4A84-AC4D-E33703B14A3CQ33632616-E4141F8C-969E-49E1-9D83-20419AA91F7FQ33690360-65BA4926-C780-478B-916F-364DEAD08BE5Q33706176-08A414F2-54EA-4ED9-A642-F52616AC8ABEQ33774643-CCEFF897-4B63-42EB-BFD0-134FA889D134Q33789802-F75EEE15-6A54-438B-9D6C-4D5C10457392Q33815579-F543A69F-B92C-420A-B529-648F86A18032Q33818511-315D39B7-9C22-4077-A91A-7EBD6D7148EEQ33827011-C9476186-ACDB-462D-8A3A-4980E6656E41Q33853430-84CE4C8E-F1FF-42D0-AF45-46C2C48FC0FDQ33909044-E93C3446-7187-42E9-933B-7216D554B745Q33917559-A0AAFDDD-7CD7-47ED-A63F-CA72BF439700Q33951695-71BF3C51-3F1C-4534-B132-02B481DDBE4FQ33967988-BE1EDDF3-7DBE-4622-B12B-B86271F965B8Q34010406-A1CE14CB-972C-4482-A736-BC48811E8815Q34048140-B2133C37-2A87-4CA6-AF44-8F5608A20F00Q34096234-CB552F5F-3857-4C70-89E8-4018B04A2419Q34106175-72813931-B270-4C4D-94C0-7613E65170FFQ34154147-B7E95F4D-ECAD-4526-A8A4-A766FBC4A785Q34334131-0D4F44B1-56C3-44B8-84B1-4163D74C36D7Q34363866-712DC0EF-1CA9-47A7-88F7-A3172A65DDDFQ34506613-54860EE2-7AE1-447D-8B47-574DC9998107Q34540766-16125940-41F5-4CAC-86A5-207F96C909A9Q34589641-D07FB63C-D956-4143-8A41-29EF8429A477Q34657786-60D15272-5FFA-4149-9647-BF6A30AD9760
P2860
Estrogen-receptor biology: continuing progress and therapeutic implications.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Estrogen-receptor biology: continuing progress and therapeutic implications.
@ast
Estrogen-receptor biology: continuing progress and therapeutic implications.
@en
type
label
Estrogen-receptor biology: continuing progress and therapeutic implications.
@ast
Estrogen-receptor biology: continuing progress and therapeutic implications.
@en
prefLabel
Estrogen-receptor biology: continuing progress and therapeutic implications.
@ast
Estrogen-receptor biology: continuing progress and therapeutic implications.
@en
P356
P1476
Estrogen-receptor biology: continuing progress and therapeutic implications.
@en
P2093
C Kent Osborne
Rachel Schiff
P304
P356
10.1200/JCO.2005.10.036
P407
P577
2005-03-01T00:00:00Z